Features

The numbers speak for themselves. There are currently 121,678 people waiting for life-saving organ transplants in the US. Of these, 100,791 await kidney transplants. A patient is added to the kidney waitlist every 14 minutes and 13 people die every day waiting for a kidney transplant (1).

Is it possible to turn unusable organs into transplantable organs? Ex vivo pulsatile machine perfusion of donor organs is a proven technique for superior organ preservation, reduced delayed graft function, and reduced ischemia-reperfusion injury. This has been the standard of care for over four decades in high-volume transplant centers.

Children with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplantation are at high risk of recurrent disease and allograft failure. A new study provides insights into long-term posttransplant survival for this group of patients.

The prevalence of diabetes is rapidly increasing and is projected to affect more than 400 million people by 2030 worldwide. Diabetic nephropathy remains the most serious microvascular complication and most frequent cause of end stage renal disease in the United States.

Understanding DNA has helped science make major strides in understanding and treating disease.

Intensive home hemodialysis (IHHD) has become an apparent alternate treatment option for ESRD patients with several clinical benefits.

Pages